Regulacion, Baby Girl .
HRN: 21-58-67 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/15/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/15/2022
07/21/2022
IVT
45mg
Q24
Psnb (thickly Meconium Amniotic Fluid, Infected Umbilical Cord)
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes